These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2612388)

  • 21. Investigations of morning and laboratory dream recall and content in depressive patients during baseline conditions and under antidepressive treatment with trimipramine.
    Riemann D; Löw H; Schredl M; Wiegand M; Dippel B; Berger M
    Psychiatr J Univ Ott; 1990 Jun; 15(2):93-9. PubMed ID: 2374795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels and therapeutic response with trimipramine treatment of endogenous depression.
    Simpson GM; Pi EH; Gross L; Baron D; November M
    J Clin Psychiatry; 1988 Mar; 49(3):113-6. PubMed ID: 3279023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls.
    Held K; Antonijevic I; Murck H; Kuenzel H; Steiger A
    Psychoneuroendocrinology; 2006 Jan; 31(1):100-7. PubMed ID: 16112814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
    Pecknold JC; Familamiri P; McClure DJ; Elie R; Chang H
    J Clin Psychiatry; 1985 May; 46(5):166-71. PubMed ID: 2859273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative trial of the antidepressant, anxiolytic, and cardiovascular effects of trimipramine and doxepin in depressed hospitalized patients.
    Assalian P; Rosengarten MD; Phillips R
    J Clin Psychiatry; 1985 Mar; 46(3):90-4. PubMed ID: 2857709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A controlled comparison of trimipramine and amitriptyline.
    Kline NS
    J Clin Psychiatry; 1982 Mar; 43(3):100-4. PubMed ID: 7037756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep-endocrine profile of the antidepressant mianserin.
    Tormey WP; Buckley MP; O'Kelly DA; Conboy J; Pinder RM; Darragh A
    Curr Med Res Opin; 1980; 6(7):456-60. PubMed ID: 7363645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial partial sleep deprivation as adjuvant treatment of depressive insomnia.
    Hemmeter U; Seifritz E; Hatzinger M; Müller MJ; Holsboer-Trachsler E
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):593-602. PubMed ID: 8588058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of trimipramine. 30 years of clinical use.
    Lapierre YD
    Drugs; 1989; 38 Suppl 1():17-24; discussion 49-50. PubMed ID: 2693051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative trial of trimipramine versus doxepin in depressed hospitalised patients.
    Assalian P; Rosengarten MD; Phillips R
    Drugs; 1989; 38 Suppl 1():32-4; discussion 49-50. PubMed ID: 2693053
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute changes in sleep-related hormone secretion of depressed patients following oral imipramine.
    Jarrett DB; Miewald JM; Kupfer DJ
    Biol Psychiatry; 1988 Sep; 24(5):541-54. PubMed ID: 3167143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative double-blind controlled study of trimipramine and amitriptyline in major depression: lack of correlation with 5-hydroxytryptamine reuptake blockade.
    Cournoyer G; de Montigny C; Ouellette J; Langlois R; Elie R; Caille G; le Morvan P
    J Clin Psychopharmacol; 1987 Dec; 7(6):385-93. PubMed ID: 3323262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimipramine in physical illness with depression.
    Rifkin A; Reardon G; Siris S; Karagji B; Kim YS; Hackstaff L; Endicott N
    J Clin Psychiatry; 1985 Feb; 46(2 Pt 2):4-8. PubMed ID: 3881418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The early effect of trimipramine (Surmontil) on gastric secretion in man.
    Myren J; Berstad A
    Scand J Gastroenterol; 1975; 10(8):817-9. PubMed ID: 1202613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effect of intravenous clomipramine upon sleep-related hormone secretion in depressed outpatients and healthy control subjects.
    Jarrett DB; Pollock B; Miewald JM; Kupfer DJ
    Biol Psychiatry; 1991 Jan; 29(1):3-14. PubMed ID: 2001445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of doxepin HCl on sleep and depression.
    Roth T; Zorick F; Wittig R; McLenaghan A; Roehrs T
    J Clin Psychiatry; 1982 Sep; 43(9):366-8. PubMed ID: 7118845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression.
    Schmid DA; Brunner H; Lauer CJ; Uhr M; Yassouridis A; Holsboer F; Friess E
    J Psychiatr Res; 2008 Oct; 42(12):991-9. PubMed ID: 18226817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longtime administration of growth hormone-releasing hormone (GHRH) does not restore the reduced efficiency of GHRH on sleep endocrine activity in 2 old-aged subjects--a preliminary study.
    Murck H; Frieboes RM; Schier T; Steiger A
    Pharmacopsychiatry; 1997 Jul; 30(4):122-4. PubMed ID: 9271777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 5HT3 receptor antagonism by tropisetron on the sleep EEG and on nocturnal hormone secretion.
    Rothe B; Guldner J; Hohlfeldt E; Lauer CJ; Pollmächer T; Holsboer F; Steiger A
    Neuropsychopharmacology; 1994 Oct; 11(2):101-6. PubMed ID: 7840861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.